- Home
- COLL vs BTBT Comparison
COLL vs BTBT Comparison
Compare COLL & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COLL | BTBT |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | COLL | BTBT |
|---|---|---|
| Price | $48.66 | $2.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $47.50 | $6.50 |
| AVG Volume (30 Days) | 494.7K | ★ 29.2M |
| Earning Date | 02-26-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.63 | 0.62 |
| Revenue | ★ $757,067,000.00 | $105,703,143.00 |
| Revenue This Year | $26.35 | $7.15 |
| Revenue Next Year | $3.67 | $90.95 |
| P/E Ratio | $29.06 | ★ $3.53 |
| Revenue Growth | ★ 26.34 | 7.86 |
| 52 Week Low | $23.23 | $1.69 |
| 52 Week High | $50.79 | $4.55 |
Technical Indicators
Market Signals| Indicator | COLL | BTBT |
|---|---|---|
| Relative Strength Index (RSI) | 58.37 | 49.58 |
| Support Level | $44.51 | $2.08 |
| Resistance Level | $50.79 | $2.24 |
| Average True Range (ATR) | 1.45 | 0.12 |
| MACD | -0.40 | 0.04 |
| Stochastic Oscillator | 63.89 | 72.18 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.